Avidity Partners Management LP
CIK 0001791827 · DALLAS, TX · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$624.4M
2026 Q2
Positions
45
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
81.9%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
DNTH
DIANTHUS THERAPEUTICS INC
32.8%
CGON
CG ONCOLOGY INC
15.9%
ORKA
ORUKA THERAPEUTICS INC
11.6%
JBIO
JADE BIOSCIENCES INC
6.1%
ELVN
ENLIVEN THERAPEUTICS INC
4.5%
CATX
PERSPECTIVE THERAPEUTICS INC
3.4%
AKTS
AKTIS ONCOLOGY INC
2.5%
PVLA
PALVELLA THERAPEUTICS INC NE
1.7%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.